National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
about
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicineDiagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)Modern approaches to HLA-haploidentical blood or marrow transplantationNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseReproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an updateNIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group ReportCorrelation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant RecipientsCurrent Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.Late effects of blood and marrow transplantation.A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantationAtopic Dermatitis-like Graft-versus-host Disease and Lichen Planus-like Graft-versus-host Disease: Alterations in Skin Barrier Function and Related Molecules.An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseAttenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of TregTLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseManagement of oral Graft versus Host Disease with topical agents: A systematic review.Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host DiseaseAssessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation.Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.More immune dysregulation: Sarcoidosis and chronic graft-versus-host disease after allogeneic stem cell transplant.Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patientsCytomegalovirus induces strong antileukemic effect in acute myeloid leukemia patients following sibling HSCT without ATG-containing regimen.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationAlemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysisLate Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseAdiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation.Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD.Sexual health in hematopoietic stem cell transplant recipients.Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
P2860
Q26740411-3585D3F5-7902-4144-9AA4-F456F9AEEAD2Q26749007-545B8110-BC40-43D0-9C08-EA83BA1F9BAEQ26797506-52AAA2A5-91CC-40DC-BE47-AC22B6633901Q26827651-5277C69E-7FB4-49C2-A4A0-2E0C34145ECBQ28076264-928521A5-B127-4772-BFCA-C26D323DA0BBQ28079998-44E28E34-7989-486F-8400-D21BFF1163F6Q28081289-4F330451-B9FB-494D-A6B8-D4540840AD39Q28391717-BA7EDFFD-4E9D-468C-A84D-BCE86F1F7403Q30240070-B7DB4E4D-DF92-4598-85EE-01D52D6F1B35Q30749782-A7251FE1-B128-45C2-9D6C-209112751597Q33441641-DC9A06C3-48CB-47ED-A679-0E8E71239833Q33574136-C8158B7B-8996-4A17-9A4E-46C8BAAAB30BQ33691510-37E4C80A-3D56-42FF-9F00-89EB52B23359Q33776886-72D93F2F-BAA4-4658-8D18-3AE00B32597AQ33798102-30DFE774-19FC-42C6-A076-03C667786531Q33798249-F7935CC4-DC09-4C3F-9620-5BC4D4928ACEQ33804224-5AF8414F-6876-4816-A268-5F136966B9D4Q33835099-F5FCDDBE-07F8-47DA-86A3-BF32711B6102Q35854915-978C0AB9-AFF9-45CB-91B1-BEF319AA3C15Q36285222-6A6427F5-DA44-4CE5-A023-D511EEED06A1Q36503766-41E1E94A-027E-445E-AE14-42F14BB9B678Q36675947-28044B8B-64AF-47C8-A0E7-F077338A6EADQ36700499-3DE04940-60B0-47C4-99EA-FD8AAED24FEBQ36707835-E5351C23-4AB4-45F6-A384-7B93BDFFF59EQ36708947-A40B304A-1EBC-4F93-9071-413A54A93967Q36712018-B7301923-BBB5-4E91-B646-9F261C3C7929Q36735696-4158D776-C94E-441C-B44B-0C2B1E4E45C8Q36742108-A4AD2E1E-F85B-4760-8980-D28F39322E95Q36841211-9D6BF854-E0AB-4947-B4CF-927137E3F924Q36891433-2272A668-D642-47FC-A231-7914909923F0Q36896996-D048BF15-4337-4295-ACE6-DA480185780FQ37041729-66DC8010-BAFE-4B82-9075-B8BFB01BCBDAQ37075979-3D2AB416-F34A-48DE-B41E-C70B67FFC6BFQ37075990-93AB02A3-3950-4699-8A15-36BC6C60AB1DQ37075998-0858422C-5638-4149-BBE8-2425E29A157DQ37076006-0E91A4B5-37C0-4E5A-9912-98E404F85A99Q37076010-2EC81935-14DC-45C1-BAC5-68F01370E5F1Q37150078-33F0B920-AE52-43F4-BDC7-5F68A529E43AQ37239517-E5D03A5A-D416-4E3B-BCE5-1F072E580333Q37241480-F33541D7-CD7C-4496-8177-5EECC74F6A8A
P2860
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
National Institutes of Health ...... Staging Working Group report.
@ast
National Institutes of Health ...... Staging Working Group report.
@en
type
label
National Institutes of Health ...... Staging Working Group report.
@ast
National Institutes of Health ...... Staging Working Group report.
@en
prefLabel
National Institutes of Health ...... Staging Working Group report.
@ast
National Institutes of Health ...... Staging Working Group report.
@en
P2093
P2860
P1476
National Institutes of Health ...... Staging Working Group report.
@en
P2093
Afonso Vigorito
Carrie L Kitko
Corey S Cutler
Daniel Weisdorf
Daniel Wolff
David Jacobsohn
Edward W Cowen
George B McDonald
Georgia B Vogelsang
Guang-Shing Cheng
P2860
P304
389-401.e1
P356
10.1016/J.BBMT.2014.12.001
P577
2014-12-18T00:00:00Z